CV risk control not up to scratch in diabetic patients Clinical study 02 February 2013 Pages: 16 - 16
Lidocaine/prilocaine + nitrous oxide/oxygen for palivizumab pain Clinical study 02 February 2013 Pages: 16 - 16
Pregabalin and duloxetine: getting to the centre of fibromyalgia News item 02 February 2013 Pages: 16 - 16
HIV infection no barrier to intensive immunochemotherapy in Burkitt's lymphoma Clinical study 02 February 2013 Pages: 17 - 17
Mycophenolate mofetil beneficial in glomerulosclerosis? Clinical study 02 February 2013 Pages: 17 - 17
Tacrolimus ointment can maintain atopic dermatitis remission Clinical study 02 February 2013 Pages: 17 - 17
IV citalopram augmentation improves depressive symptoms in treatment-resistant depression Clinical study 02 February 2013 Pages: 18 - 18
Prophylactic lamivudine reduces risk of MTCT of HIV-1 infections News item 02 February 2013 Pages: 18 - 18
Raloxifene reduces breast cancer risk in women with CHD Clinical study 02 February 2013 Pages: 18 - 18
Preoperative statins clinically beneficial in heart surgery Clinical study 02 February 2013 Pages: 19 - 19
Rituximab takes on rheumatoid arthritis at the front line Clinical study 02 February 2013 Pages: 19 - 19
Sulbactam/ampicillin top in fight against Acinetobacter spp. Clinical study 02 February 2013 Pages: 19 - 19
Rupatadine realises results for persistent allergic rhinitis Clinical study 02 February 2013 Pages: 20 - 20
Somatropin decreases visceral fat, improves CV risk markers Clinical study 02 February 2013 Pages: 20 - 20
Rapid onset of effect with ER dexmethylphenidate in kids Clinical study 02 February 2013 Pages: 21 - 21
Salmeterol recipients may breathe easier after meta-analysis News item 02 February 2013 Pages: 21 - 21
Biopten [sapropterin] approved in Japan for phenylketonuria. Media release 02 February 2013 Pages: 22 - 22
Differin Gel 0.1% [adapalene] received marketing approval in Japan. Media release 02 February 2013 Pages: 22 - 22
Generics to hold one fifth of Brazilian pharma market by 2012 Media release 02 February 2013 Pages: 22 - 22
Misoprostol may ameliorate diclofenac's cardiorenal effects Clinical study 02 February 2013 Pages: 22 - 22
Risedronic acid approved for Paget's disease of bone in Japan. Media release 02 February 2013 Pages: 22 - 22
Once-daily tacrolimus receives marketing approval in Japan. Media release 02 February 2013 Pages: 23 - 23
PhiloGene's VEGFb granted orphan drug status in US for advanced melanoma. Media release 02 February 2013 Pages: 23 - 23
Xanodyne receives approvable letter from US FDA for diclofenac potassium. Media release 02 February 2013 Pages: 23 - 23